Ajooni Biotech approves unaudited Q2 and H1 FY2026 financial results for the quarter and half-year ended September 30, 2025, with Limited Review Report from the auditor.
AI Assistant
Ajooni Biotech Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.